(Q44659267)

5 December 2017

title

No association of tumor necrosis factor alpha gene polymorphisms with schizophrenia or response to clozapine (English)

1 reference

5 December 2017

0 references

1

1 reference

5 December 2017

Chen-Jee Hong

2

1 reference

5 December 2017

Younger W-Y Yu

series ordinal

3

1 reference

5 December 2017

Ching-Hua Lin

series ordinal

4

1 reference

5 December 2017

Ling-Ling Liu

series ordinal

5

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

5 December 2017

published in

Schizophrenia Research

1 reference

5 December 2017

volume

65

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

27-32

1 reference

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

Clozapine. A novel antipsychotic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

Association between −G308A tumor necrosis factor alpha gene polymorphism and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

Maternal cytokine levels during pregnancy and adult psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

Neuroleptics normalize increased release of interleukin- 1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

No evidence for association of serotonin-2A receptor variant (102T/C) with schizophrenia or clozapine response in a Chinese population

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

A differential role for interleukin-6 and tumor necrosis factor-alpha in schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

Tumor necrosis factor (TNF).

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

Tumor necrosis factor-alpha: a neuromodulator in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

Pathogenetic mechanisms of septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

All out for chromosome six

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

Effects of clozapine on plasma cytokine and soluble cytokine receptor levels

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

Association study of a functional serotonin transporter gene polymorphism with schizophrenia, psychopathology and clozapine response

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

Tumor necrosis factor receptor-II: heritability and effect on brain morphology in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

The NOTCH4 locus is associated with susceptibility to schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900531-5

7 January 2021

10.1016/S0920-9964(02)00531-5

Identifiers

DOI

1 reference

5 December 2017

1 reference